| Mar 31,
2018 | Mar 31,
2019 | Mar 31,
2020 | Mar 31,
2021 | Mar 31,
2022 | Mar 31,
2024 |
|---|
| Revenue | 2,830 | 3,304 | 3,623 | - | - | 4,283 |
|---|
| Cost of sales | 1,953 | 2,363 | 2,540 | - | - | 3,128 |
|---|
| Gross profit | 877 | 942 | 1,084 | - | - | 1,155 |
|---|
| Research and development expense | 115 | 101 | 138 | - | - | 150 |
|---|
| Selling, general and administrative expense | 381 | 415 | 438 | - | - | 535 |
|---|
| Other (gains) and losses | 37 | 22 | 1 | - | - | -28 |
|---|
| Share of after-tax profit of equity accounted investees | 42 | 33 | 28 | - | - | 72 |
|---|
| Restructuring, integration and acquisition costs | - | - | - | - | - | 131 |
|---|
| Impairment of goodwill | - | - | - | - | - | 568 |
|---|
| Operating (loss) income | 461 | 481 | 537 | - | - | -185 |
|---|
| Finance expense – net | -76 | -81 | -144 | - | - | -205 |
|---|
| (Loss) earnings before income taxes | 385 | 400 | 393 | - | - | -390 |
|---|
| Tax expense (income) | 29 | 60 | 74 | - | - | -73 |
|---|
| Net (loss) income from continuing operations | 356 | - | - | - | - | -318 |
|---|
| Net income from discontinued operations | - | - | - | - | - | 21 |
|---|
| Net (loss) income | 356 | 340 | 319 | -47 | 150 | -296 |
|---|
| Equity holders of the Company | 347 | 330 | 311 | - | - | -304 |
|---|
| Non-controlling interests | 9 | 10 | 8 | -0 | 8 | 8 |
|---|
| Basic earnings (loss) per share from continuing operations | 1.29 | 1.24 | 1.17 | - | - | -1.02 |
|---|
| Diluted earnings (loss) per share from continuing operations | 1.29 | 1.23 | 1.16 | - | - | -1.02 |
|---|
| Basic earnings (loss) per share from discontinued operations | - | - | - | - | - | 0.07 |
|---|
| Diluted earnings (loss) per share from discontinued operations | - | - | - | - | - | 0.07 |
|---|